medRxiv PreprintsInternational20 November 2026
Refining Cardiovascular-Kidney-Metabolic Risk Assessment Across the Heart Failure Spectrum
This is an official announcement record
Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.
Background: The cardiovascular-kidney-metabolic (CKM) framework emphasizes risk assessment and prevention of heart failure (HF). However, the prognostic implications and optimal assessment of CKM burden in established HF remain uncertain. Objectives: To evaluate the prognostic value of binary and HF-adapted graded CKM burden scores across HF phenotypes. Methods: We evaluated 2 independent HF cohorts comprising patients with HF with reduced ejection fraction (HFrEF) initiating angiotensin receptor-neprilysin inhibitor therapy (HFrEF-ARNI; n=1,450) and patients hospitalized for acute HF (AHF; n
Read the official announcement
Opens www.medrxiv.org
More from medRxiv Preprints
- Unmet needs of Polish patients with cystic fibrosis seen through the lens of crowdfunding20 November 2026
- Motherly Plus: Study Protocol of a Randomized Controlled Trial Evaluating a Smartphone-Assisted Single-Session Psychotherapy Intervention for Postpartum Depression20 November 2026
- Targeting memory consolidation in major depression via pharmacological slow-wave sleep promotion20 November 2026
- Epidemiology of Cardiac Structure and Function Among African Caribbeans in Tobago: A Population-based Cohort Study20 November 2026
- Depressive Symptom Trajectories and Incident Cognitive Impairment by Outcome Ascertainment20 November 2026
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.